Salts and Solid Forms of 4-hydroxy-N,N-diisopropyltryptamine
Summary
The USPTO has published a patent application detailing new salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DIPT), including hemi-glutarate and hemi-succinate forms. These forms are disclosed for their potential use in treating neurological and psychiatric disorders.
What changed
This document is a USPTO patent application (US20260085041A1) for novel salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DIPT), specifically hemi-glutarate and hemi-succinate variants. The application also covers methods for preparing and administering these compounds, highlighting their potential therapeutic applications in treating neurological diseases and psychiatric disorders.
As this is a patent application, it does not impose immediate compliance obligations on regulated entities. However, it signals potential future intellectual property protection and market exclusivity for these specific chemical entities and their uses. Companies involved in pharmaceutical research and development, particularly in the areas of neurology and psychiatry, should monitor this application's progress and consider its implications for their own research and development pipelines.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SALTS AND SOLID FORMS OF 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE HEMI-GLUTARATE AND HEMI-SUCCINATE
Application US20260085041A1 Kind: A1 Mar 26, 2026
Inventors
Samuel CLARK
Abstract
Disclosed herein are salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine hemi-glutarate (4-OH-DIPT), e.g., 4-OH-DIPT hemi-glutarate, 4-OH-DIPT hemi-succinate, 4-OH-DIPT hemi-succinate hydrochloride, and 4-OH-DIPT hemi-glutarate hydrochloride. The solid form may be a salt and/or a crystalline form of the 4-OH-DIPT, such as a polymorph of 4-OH-DIPT or a salt thereof. Also disclosed are methods for making the solid forms and methods for administering the solid forms. The disclosed solid forms of 4-OH-DIPT are useful for treating neurological disease and/or a psychiatric disorder in a subject.
CPC Classifications
C07D 209/16 A61K 31/36 A61K 31/4045 A61K 45/06 A61P 25/32
Filing Date
2025-12-03
Application No.
19408193
Related changes
Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.